Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?
出版年份 2012 全文链接
标题
Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?
作者
关键词
-
出版物
Annals of the New York Academy of Sciences
Volume 1274, Issue 1, Pages 48-59
出版商
Wiley
发表日期
2012-12-19
DOI
10.1111/j.1749-6632.2012.06824.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice
- (2012) Rinse Klooster et al. BRAIN
- An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib
- (2012) Ravi Vij et al. BRITISH JOURNAL OF HAEMATOLOGY
- Elotuzumab in Combination With Lenalidomide and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
- (2012) Sagar Lonial et al. JOURNAL OF CLINICAL ONCOLOGY
- Homing and Adhesion Patterns Determine the Cellular Composition of the Bone Marrow Plasma Cell Niche
- (2012) E. Belnoue et al. JOURNAL OF IMMUNOLOGY
- Long-lasting treatment effect of rituximab in MuSK myasthenia
- (2012) J. Diaz-Manera et al. NEUROLOGY
- Plerixafor as First- and Second-Line Strategies for Autologous Stem Cell Mobilization in Patients with Non-Hodgkin's Lymphoma or Multiple Myeloma
- (2012) Kevin W. Lor et al. PHARMACOTHERAPY
- Discovery and Development of Second-Generation Proteasome Inhibitors
- (2012) Christopher J. Kirk SEMINARS IN HEMATOLOGY
- Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity
- (2012) YK Onno Teng et al. ARTHRITIS RESEARCH & THERAPY
- Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells
- (2011) H. Travis Ichikawa et al. ARTHRITIS AND RHEUMATISM
- Distinct phenotypes of plasma cells in spleen and bone marrow of autoimmune NOD.B10.H2b mice
- (2011) Ewa A. Szyszko et al. AUTOIMMUNITY
- The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications
- (2011) Klaus Podar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma
- (2011) Sally A. Hunsucker et al. BRITISH JOURNAL OF HAEMATOLOGY
- Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
- (2011) S. Arastu-Kapur et al. CLINICAL CANCER RESEARCH
- Proteasome inhibitor treatment of antibody-mediated allograft rejection
- (2011) E. Steve Woodle et al. Current Opinion in Organ Transplantation
- Successful Treatment of a Patient with Rheumatoid Arthritis and IgA-Kappa Multiple Myeloma with Tocilizumab
- (2011) Yasushi Matsuyama et al. INTERNAL MEDICINE
- Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis
- (2011) A. M. Gomez et al. JOURNAL OF IMMUNOLOGY
- Myeloperoxidase-Specific Plasma Cell Depletion by Bortezomib Protects from Anti-Neutrophil Cytoplasmic Autoantibodies-Induced Glomerulonephritis
- (2011) J. Bontscho et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Bortezomib delays the onset of factor VIII inhibitors in experimental hemophilia A, but fails to eliminate established anti-factor VIII IgG-producing cells
- (2011) Y. MESLIER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Therapeutic inhibition of proteasomes in systemic lupus erythematosus
- (2011) Falk Hiepe et al. Journal of Translational Medicine
- Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
- (2011) Philippe Moreau et al. LANCET ONCOLOGY
- Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
- (2011) Falk Hiepe et al. Nature Reviews Rheumatology
- Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection
- (2011) J. Waiser et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Early and Late Acute Antibody-Mediated Rejection Differ Immunologically and in Response to Proteasome Inhibition
- (2011) R. Carlin Walsh et al. TRANSPLANTATION
- The Impact of Proteasome Inhibition on Alloantibody-Producing Plasma Cells In Vivo
- (2011) Tayyab S. Diwan et al. TRANSPLANTATION
- Successful treatment of IgG and complement-mediated autoimmune hemolytic anemia with bortezomib and low-dose cyclophosphamide
- (2010) Pongwut Danchaivijitr et al. AMERICAN JOURNAL OF HEMATOLOGY
- Bortezomib as the Sole Post-Renal Transplantation Desensitization Agent Does Not Decrease Donor-Specific Anti-HLA Antibodies
- (2010) R. Sberro-Soussan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis
- (2010) Osamu Higuchi et al. ANNALS OF NEUROLOGY
- Successful use of bortezomib in a patient with systemic lupus erythematosus and multiple myeloma
- (2010) K. Frohlich et al. ANNALS OF THE RHEUMATIC DISEASES
- Antibody effector mechanisms in myasthenia gravis—Pathogenesis at the neuromuscular junction
- (2010) Alejandro M. Gomez et al. AUTOIMMUNITY
- Immunosuppressive therapies in myasthenia gravis
- (2010) Donald B. Sanders et al. AUTOIMMUNITY
- Successful treatment of IgM-mediated autoimmune hemolytic anemia with bortezomib
- (2010) K. R. Carson et al. BLOOD
- Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
- (2010) S. Bringhen et al. BLOOD
- Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
- (2010) M. de Weers et al. JOURNAL OF IMMUNOLOGY
- Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies
- (2010) Guido Cavaletti et al. LEUKEMIA & LYMPHOMA
- Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat
- (2010) R. Vogelbacher et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Protective Immunity Remains Intact After Antibody Removal by Means of Proteasome Inhibition
- (2010) Matthew J. Everly et al. TRANSPLANTATION
- Proteasome Inhibitor-Based Primary Therapy for Antibody-Mediated Renal Allograft Rejection
- (2010) R Carlin Walsh et al. TRANSPLANTATION
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo
- (2009) H. Ikeda et al. CLINICAL CANCER RESEARCH
- Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy
- (2009) Paul G. Richardson et al. JOURNAL OF CLINICAL ONCOLOGY
- Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production
- (2008) D. K. Perry et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The myasthenia gravis thymus: A rare source of human autoantibody-secreting plasma cells for testing potential therapeutics
- (2008) Marguerite E. Hill et al. JOURNAL OF NEUROIMMUNOLOGY
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
- Maintenance of the plasma cell pool is independent of memory B cells
- (2008) A. Ahuja et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection
- (2008) Matthew J. Everly et al. TRANSPLANTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started